Lady Gaga Partners with Pfizer to Raise Migraine Awareness
June is Migraine and Headache Awareness Month, and in keeping with this year’s theme, “Educate Yourself, Educate Others,” Pfizer is partnering with Lady Gaga to raise awareness of this often-misunderstood disease.
Affecting about 40 million people in the United States and one billion people globally, migraine is a debilitating and recurrent neurological disease. In fact, according to one study, migraine is considered the second-most disabling condition in the world, following low back pain.1,2
An Academy Award®, Golden Globe® Award, and 13-time Grammy® Award-winning actress and philanthropist, Lady Gaga was diagnosed with migraine when she was 14 years old, and it has had a profound impact on her life.
“Lady Gaga’s story is a powerful reminder of how significantly migraine affects the lives of so many people,” says Angela Lukin, Global Primary Care and U.S. President, Pfizer. “We believe that this collaboration will help raise awareness of this often ‘silent’ disease and inspire those living with migraine to have conversations with their healthcare providers about the best way to manage their condition.”
By showcasing Lady Gaga’s experience, Pfizer hopes to help people better understand the effect migraine can have on their lives and to show people living with the disease that they are not alone.
- Buse et al. Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine. Journal of Managed Care & Specialty Pharmacy. 2020;26(10):1334-1343.
- GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018;17(11):954-976.
02.23.2024 Diversity & Inclusion Employees Responsibility Pfizer’s Statement on Results of Fifth Annual Pay Equity Study Among Colleagues Worldwide 02.12.2024 Albert Bourla Leadership Technology January Social Media Round-Up—Celebrating 175, Discussing AI, and Attending CES 2024 02.12.2024 Cancer Employees History Patient Centricity Pfizer Kicks Off 175th Anniversary by Looking Back at Legacy and Ahead to the Future 02.06.2024 Medicines Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer 02.05.2024 Cancer Health Equity Oncology Partnerships “Change the Odds” Brings Pfizer Together with the American Cancer Society to Bridge the Gap in Cancer Care Disparities